-
公开(公告)号：US20110027181A1
公开(公告)日：2011-02-03
申请号：US12802148
申请日：2010-05-28
申请人： Dario G. Amodei , Mahalaxmi Gita Bangera , Xiaoyan Robert Bao , Anna Bershteyn , Brett Bethke , Philip A. Eckhoff , Kevin Michael Esvelt , Kyle B. Gustafson , Edward K.Y. Jung , William Michael Kaminsky , Jordin T. Kare , Lily Yvonne Kim , Eric C. Leuthardt , Erez Lieberman , Ankur Moitra , Christopher Somogyi , Clarence T. Tegreene , Lowell L. Wood, JR. , Jeremiah James Zartman
发明人： Dario G. Amodei , Mahalaxmi Gita Bangera , Xiaoyan Robert Bao , Anna Bershteyn , Brett Bethke , Philip A. Eckhoff , Kevin Michael Esvelt , Kyle B. Gustafson , Edward K.Y. Jung , William Michael Kaminsky , Jordin T. Kare , Lily Yvonne Kim , Eric C. Leuthardt , Erez Lieberman , Ankur Moitra , Christopher Somogyi , Clarence T. Tegreene , Lowell L. Wood, JR. , Jeremiah James Zartman
IPC分类号： A61K49/00 , A61K9/00 , A61K35/12 , A61K35/68 , A61K35/74 , A61K35/64 , A61K35/00 , A61P43/00
CPC分类号： A61K9/0024 , A61K47/6901 , A61L27/54 , A61L31/16 , A61L2300/258 , B33Y80/00 , Y02A50/411
摘要： Devices, methods, and systems are described for administration to at least one biological tissue of at least one device including at least one altered microorganism. In an embodiment, the altered microorganism includes at least one nucleic acid construct encoding at least one therapeutic agent.
-
公开(公告)号：US20110028945A1
公开(公告)日：2011-02-03
申请号：US12802149
申请日：2010-05-28
申请人： Dario G. Amodei , Mahalaxmi Gita Bangera , Xiaoyan Robert Bao , Anna Bershteyn , Brett Bethke , Philip A. Eckhoff , Kevin Michael Esvelt , Kyle B. Gustafson , Edward K.Y. Jung , William Michael Kaminsky , Jordin T. Kare , Lily Yvonne Kim , Eric C. Leuthardt , Erez Lieberman , Ankur Moitra , Christopher Somogyi , Clarence T. Tegreene , Lowell L. Wood, JR. , Jeremiah James Zartman
发明人： Dario G. Amodei , Mahalaxmi Gita Bangera , Xiaoyan Robert Bao , Anna Bershteyn , Brett Bethke , Philip A. Eckhoff , Kevin Michael Esvelt , Kyle B. Gustafson , Edward K.Y. Jung , William Michael Kaminsky , Jordin T. Kare , Lily Yvonne Kim , Eric C. Leuthardt , Erez Lieberman , Ankur Moitra , Christopher Somogyi , Clarence T. Tegreene , Lowell L. Wood, JR. , Jeremiah James Zartman
IPC分类号： A61M37/00
CPC分类号： G01N33/48 , A61K9/0024 , A61K47/6901 , A61L27/54 , A61L31/16 , A61L2300/258 , G06F19/00 , G06F19/3468 , Y02A90/26
摘要： Devices, methods, and systems are described for administration to at least one biological tissue of at least one device including at least one altered microorganism. In an embodiment, the altered microorganism includes at least one nucleic acid construct encoding at least one therapeutic agent.
-
3.发明授权公开(公告)号：US08734823B2
公开(公告)日：2014-05-27
申请号：US12802148
申请日：2010-05-28
申请人： Dario G. Amodei , Mahalaxmi Gita Bangera , Xiaoyan Robert Bao , Anna Bershteyn , Brett Bethke , Philip A. Eckhoff , Kevin Michael Esvelt , Kyle B. Gustafson , Edward K. Y. Jung , William Michael Kaminsky , Jordin T. Kare , Lily Yvonne Kim , Eric C. Leuthardt , Erez Lieberman , Ankur Moitra , Christopher Somogyi , Clarence T. Tegreene , Lowell L. Wood, Jr. , Jeremiah James Zartman
发明人： Dario G. Amodei , Mahalaxmi Gita Bangera , Xiaoyan Robert Bao , Anna Bershteyn , Brett Bethke , Philip A. Eckhoff , Kevin Michael Esvelt , Kyle B. Gustafson , Edward K. Y. Jung , William Michael Kaminsky , Jordin T. Kare , Lily Yvonne Kim , Eric C. Leuthardt , Erez Lieberman , Ankur Moitra , Christopher Somogyi , Clarence T. Tegreene , Lowell L. Wood, Jr. , Jeremiah James Zartman
CPC分类号： A61K9/0024 , A61K47/6901 , A61L27/54 , A61L31/16 , A61L2300/258 , B33Y80/00 , Y02A50/411
摘要： Devices, methods, and systems are described for administration to at least one biological tissue of at least one device including at least one altered microorganism. In an embodiment, the altered microorganism includes at least one nucleic acid construct encoding at least one therapeutic agent.
摘要翻译： 描述了将装置，方法和系统用于给予至少一种包含至少一种改变的微生物的装置的至少一种生物组织。 在一个实施方案中，改变的微生物包括至少一种编码至少一种治疗剂的核酸构建体。
-
公开(公告)号：US08682619B2
公开(公告)日：2014-03-25
申请号：US12802149
申请日：2010-05-28
申请人： Dario G. Amodei , Mahalaxmi Gita Bangera , Xiaoyan Robert Bao , Anna Bershteyn , Brett Bethke , Philip A. Eckhoff , Kevin Michael Esvelt , Kyle B. Gustafson , Edward K. Y. Jung , William Michael Kaminsky , Jordin T. Kare , Lily Yvonne Kim , Eric C. Leuthardt , Erez Lieberman , Ankur Moitra , Christopher Somogyi , Clarence T. Tegreene , Lowell L. Wood, Jr. , Jeremiah James Zartman
发明人： Dario G. Amodei , Mahalaxmi Gita Bangera , Xiaoyan Robert Bao , Anna Bershteyn , Brett Bethke , Philip A. Eckhoff , Kevin Michael Esvelt , Kyle B. Gustafson , Edward K. Y. Jung , William Michael Kaminsky , Jordin T. Kare , Lily Yvonne Kim , Eric C. Leuthardt , Erez Lieberman , Ankur Moitra , Christopher Somogyi , Clarence T. Tegreene , Lowell L. Wood, Jr. , Jeremiah James Zartman
CPC分类号： G01N33/48 , A61K9/0024 , A61K47/6901 , A61L27/54 , A61L31/16 , A61L2300/258 , G06F19/00 , G06F19/3468 , Y02A90/26
摘要： Devices, methods, and systems are described for administration to at least one biological tissue of at least one device including at least one altered microorganism. In an embodiment, the altered microorganism includes at least one nucleic acid construct encoding at least one therapeutic agent.
-
5.发明申请公开(公告)号：US20110172826A1
公开(公告)日：2011-07-14
申请号：US12806637
申请日：2010-05-28
申请人： Dario G. Amodei , Mahalaxmi Gita Bangera , Xiaoyan Robert Bao , Anna Bershteyn , Brett Bethke , Philip A. Eckhoff , Kevin Michael Esvelt , Kyle Gustafson , Edward K.Y. Jung , William Michael Kaminsky , Jordin T. Kare , Lily Yvonne Kim , Eric C. Leuthardt , Erez Lieberman , Ankur Moitra , Christopher Somogyi , Clarence T. Tegreene , Lowell L. Wood, JR. , Jeremiah James Zartman
发明人： Dario G. Amodei , Mahalaxmi Gita Bangera , Xiaoyan Robert Bao , Anna Bershteyn , Brett Bethke , Philip A. Eckhoff , Kevin Michael Esvelt , Kyle Gustafson , Edward K.Y. Jung , William Michael Kaminsky , Jordin T. Kare , Lily Yvonne Kim , Eric C. Leuthardt , Erez Lieberman , Ankur Moitra , Christopher Somogyi , Clarence T. Tegreene , Lowell L. Wood, JR. , Jeremiah James Zartman
IPC分类号： G05B21/00
CPC分类号： C12N1/36 , A61K9/0024 , A61K47/6901 , A61L27/54 , A61L31/16 , A61L2300/258
摘要： Devices, methods, and systems are described for administration to at least one biological tissue of at least one device including at least one altered microorganism. In an embodiment, the altered microorganism includes at least one nucleic acid construct encoding at least one therapeutic agent.
摘要翻译： 描述了将装置，方法和系统用于给予至少一种包含至少一种改变的微生物的装置的至少一种生物组织。 在一个实施方案中，改变的微生物包括至少一种编码至少一种治疗剂的核酸构建体。
-
6.发明授权公开(公告)号：US08206975B2
公开(公告)日：2012-06-26
申请号：US11588852
申请日：2006-10-27
CPC分类号： B01L3/5027 , B01L3/502707 , B01L3/502738 , B01L3/502761 , B01L2200/0647 , B01L2300/0816 , B01L2300/0861 , B01L2400/0487 , B01L2400/0655 , B01L2400/084 , G01N1/18 , Y10T137/206 , Y10T137/2076 , Y10T137/2267 , Y10T436/25375
摘要： A method and a microfluidic device are provided to regulate fluid flow by equalization of channel pressures. The fluid flow is regulated by way of valve-actuated channel pressures.
摘要翻译： 提供了一种方法和微流体装置，用于通过平衡通道压力来调节流体流动。 流体流动通过阀致动通道压力进行调节。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.077 秒)
